Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03819465
Title A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC (MAGELLAN)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

lung non-small cell carcinoma

Therapies

Gemcitabine

Durvalumab + Oleclumab

Carboplatin

Pemetrexed Disodium

Nab-paclitaxel

AZD9150 + Durvalumab

Cisplatin

Durvalumab

Age Groups: senior | adult
Covered Countries USA | ESP | CAN | BEL | AUT

Facility Status City State Zip Country Details
Research Site Iowa City Iowa 52242 United States Details
Research Site Pittsburgh Pennsylvania 15212 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Salzburg 5020 Austria Details
Research Site Wien 1140 Austria Details
Research Site Edegem 2650 Belgium Details
Research Site Edmonton Alberta T6G 1Z2 Canada Details
Research Site Ottawa Ontario K1H 8L6 Canada Details
Research Site Toronto M5G 2M9 Canada Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 05505 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Bialystok 15-027 Poland Details
Research Site Bydgoszcz 85-796 Poland Details
Research Site Gdańsk 80-214 Poland Details
Research Site Grudziądz 86-300 Poland Details
Research Site Olsztyn 10-357 Poland Details
Research Site Tomaszów Mazowiecki 97-200 Poland Details
Research Site Warszawa 02-781 Poland Details
Research Site Wroclaw 53-413 Poland Details
Research Site Krasnoyarsk 660133 Russian Federation Details
Research Site Moscow 115478 Russian Federation Details
Research Site Saint Petersburg 197758 Russian Federation Details
Research Site Sankt-Peterburg 197758 Russian Federation Details
Research Site St.Petersburg 191014 Russian Federation Details
Research Site Barcelona 08025 Spain Details
Research Site Barcelona 08035 Spain Details
Research Site Barcelona 8003 Spain Details
Research Site Madrid 28034 Spain Details
Research Site Madrid 28041 Spain Details
Research Site Sevilla 41013 Spain Details
Research Site Kaohsiung 807 Taiwan Details
Research Site Taichung City 402 Taiwan Details
Research Site Taichung 40705 Taiwan Details
Research Site Tainan City 70403 Taiwan Details
Research Site Taipei 10002 Taiwan Details
Research Site Taipei 112 Taiwan Details
Research Site Taipei 235 Taiwan Details
Research Site Taoyuan 333 Taiwan Details
Research Site Bangkok 10330 Thailand Details
Research Site Bangkok 10700 Thailand Details
Research Site Chiang Mai 50200 Thailand Details
Research Site Hat Yai 90110 Thailand Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field